Potent antibody therapeutics by design
PJ Carter - Nature reviews immunology, 2006 - nature.com
Nature reviews immunology, 2006•nature.com
Antibodies constitute the most rapidly growing class of human therapeutics and the second
largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I
review here, is an iterative design process that involves the generation and optimization of
antibodies to improve their clinical potential.
largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I
review here, is an iterative design process that involves the generation and optimization of
antibodies to improve their clinical potential.
Abstract
Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I review here, is an iterative design process that involves the generation and optimization of antibodies to improve their clinical potential.
nature.com